NeuroOne Medical Technologies Corp. (NMTC)
1.62
-0.04
(-2.41%)
USD |
NASDAQ |
Sep 04, 16:00
1.64
+0.02
(+1.23%)
After-Hours: 20:00
NeuroOne Medical Technologies Total Assets (Quarterly) : 6.186M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.186M |
| March 31, 2026 | 7.569M |
| December 31, 2025 | 8.578M |
| September 30, 2025 | 10.88M |
| June 30, 2025 | 10.82M |
| March 31, 2025 | 4.457M |
| December 31, 2024 | 6.494M |
| September 30, 2024 | 5.370M |
| June 30, 2024 | 4.913M |
| March 31, 2024 | 5.395M |
| December 31, 2023 | 5.822M |
| September 30, 2023 | 8.097M |
| June 30, 2023 | 5.758M |
| March 31, 2023 | 7.205M |
| December 31, 2022 | 9.660M |
| September 30, 2022 | 12.82M |
| June 30, 2022 | 11.57M |
| March 31, 2022 | 14.09M |
| December 31, 2021 | 17.18M |
| September 30, 2021 | 7.938M |
| June 30, 2021 | 9.809M |
| March 31, 2021 | 11.92M |
| December 31, 2020 | 7.913M |
| September 30, 2020 | 4.760M |
| June 30, 2020 | 4.462M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.389M |
| December 31, 2019 | 2.659M |
| September 30, 2019 | 0.5326M |
| June 30, 2019 | 1.536M |
| March 31, 2019 | 2.575M |
| December 31, 2018 | 0.5775M |
| September 30, 2018 | 0.2187M |
| June 30, 2018 | 0.2297M |
| March 31, 2018 | 0.2438M |
| December 31, 2017 | 0.25M |
| September 30, 2017 | 0.2678M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.7569M |
| September 30, 2016 | 0.0043M |
| June 30, 2016 | 0.0043M |
| March 31, 2016 | 0.0018M |
| December 31, 2015 | 0.0018M |
| September 30, 2015 | 0.0002M |
| June 30, 2015 | 0.0004M |
| March 31, 2015 | 0.0002M |
| December 31, 2014 | 0.0002M |
| September 30, 2014 | 0.0006M |
| June 30, 2014 | 0.0007M |
| March 31, 2014 | 0.0005M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Abbott Laboratories | 109.22B |
| AngioDynamics, Inc. | 267.16M |
| Alphatec Holdings, Inc. | 791.03M |
| AtriCure, Inc. | 676.64M |
| Baxter International, Inc. | 19.79B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.419M |
| Shareholders Equity (Quarterly) | 3.768M |
| Debt to Equity Ratio | 0.0465 |
| Current Ratio | 2.820 |
| Net Debt Paydown Yield | 0.10% |